X

We're getting an entirely new look!

We invite you to preview our early beta release ...

No Thanks
OK, Take Me to the Beta Site
University of California, San Francisco.
Drug Industry Document Archives.

Title: Merck Clinical Study Report. Assessment of Differences Between Vioxx and Naproxen to Ascertain Gastrointestinal Tolerability and Effectiveness (ADVANTAGE)
Document Date: 20010329
Person Author: Geba, Greg; O'Brien, Katherine; Polis, Adam; Pyeron, Ann; Skalky, Carol
Corporate Author: Merck and Co.
Corporate Recipient: U.S. Food and Drug Administration
Document Type: report, scientific
Named Person: Bellamy, N; Blyskal, Stanley; Codding, Christine; Crofford, LJ; Desir, Deborah; Dewan, Meera; Felson, David T.; Fox, Donald; Gozzi, Margareta; Greenberg, Roy; Guess, HA; Horn, Arthur; Juhlin, Roger; Khan, Misal; Khosla, Rakesh; Koval, Norman; Lee, SH; Lisecki, Edward; Lyons-Giordano, B; Maestrello, Steven; Masferrer, JL; Meade, EA; Mitchell, JA; Pacheco, Leroy; Patel, Rajesh; Popeil, Larry; Posey, Michael; Pritchard, KA; Schechtman, Joy; Shoemaker, James; Smith, Timothy; Walker, AM; Yamagata, K
Named Organization: Bristol-Myers Squibb; Merck and Co.; National Institutes of Health; Pennington Biomedial Research Center; PPD Pharmaco; SmithKline Beecham; The William Harvey Research Institute
Collection: Humeston v. Merck
Bates Number: MRKNJ0221292-MRKNJ0221423
Date Added UCSF: 20081125
Page Count: 132
Casename: Frederick Humeston v Merck & Co.; Brian Hermans v Merck & Co.
View as: PDF
Bookmark: http://dida.library.ucsf.edu/tid/vio20x10
 
Legal      Privacy      Contact Us

  UCSF Library University of California, San Francisco ©2011 The Regents of the University of California